117 related articles for article (PubMed ID: 1764697)
1. Augmentation of cytotoxicity using combinations of interferons (types I and II), tumor necrosis factor-alpha, and tamoxifen in MCF-7 cells.
Tiwari RK; Wong GY; Liu J; Miller D; Osborne MP
Cancer Lett; 1991 Dec; 61(1):45-52. PubMed ID: 1764697
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
Matsuo S; Takano S; Yamashita J; Ogawa M
Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.
Lindner DJ; Kolla V; Kalvakolanu DV; Borden EC
Mol Cell Biochem; 1997 Feb; 167(1-2):169-77. PubMed ID: 9059994
[TBL] [Abstract][Full Text] [Related]
4. Additive and synergistic antitumor effects with toremifene and interferons.
Kangas L; Cantell K; Schellekens H
J Steroid Biochem; 1990 Jun; 36(3):259-62. PubMed ID: 2142249
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha and gamma mediated gene responses in a human breast carcinoma cell line.
Tiwari RK; Wong GY; Mukhopadhyay B; Telang NT; Liu J; Hakes TB; Osborne MP
Breast Cancer Res Treat; 1991 Mar; 18(1):33-41. PubMed ID: 1713085
[TBL] [Abstract][Full Text] [Related]
7. A distinct kinase modulates the expression of IFN-inducible genes in human breast cancer cells.
Tiwari RK; Osborne MP
Cancer Lett; 1991 Jul; 59(1):31-6. PubMed ID: 1715233
[TBL] [Abstract][Full Text] [Related]
8. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
[TBL] [Abstract][Full Text] [Related]
9. Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.
Rotondi M; Coperchini F; Sideri R; Groppelli G; de Martinis L; Villani L; Pignatti P; Magri F; Chiovato L
J Interferon Cytokine Res; 2013 Sep; 33(9):508-13. PubMed ID: 23675779
[TBL] [Abstract][Full Text] [Related]
10. The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study.
Namazi S; Rostami-Yalmeh J; Sahebi E; Jaberipour M; Razmkhah M; Hosseini A
Biomed Pharmacother; 2014 Jun; 68(5):565-71. PubMed ID: 24975086
[TBL] [Abstract][Full Text] [Related]
11. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
13. Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer.
Porzsolt F; Otto AM; Trauschel B; Buck C; Wawer AW; Schönenberger H
J Cancer Res Clin Oncol; 1989; 115(5):465-9. PubMed ID: 2478560
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
15. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of cytotoxic activity of recombinant human tumor necrosis factor (rHu-TNF) by recombinant human interferon-gamma (rHu-IFN-gamma).
Taguchi T; Kimoto Y; Tanji Y; Abe S; Nakano K; Sohmura Y
J Biol Response Mod; 1987 Dec; 6(6):599-609. PubMed ID: 3131488
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8).
Nanes MS; McKoy WM; Marx SJ
Endocrinology; 1989 Jan; 124(1):339-45. PubMed ID: 2491807
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
20. Autocrine interferon-γ may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype.
Niu XL; Wang Y; Yao Z; Duan H; Li Z; Liu W; Zhang H; Deng WM
Oncol Rep; 2015 Dec; 34(6):3120-30. PubMed ID: 26397740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
